Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: Results from a 5‐year period
| Autor: | Anne Birgitte Simonsen, Jeanne D. Johansen, Jacob P. Thyssen, Ulrik Ahrensbøll-Friis, Claus Zachariae |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Allergy Adolescent medicine.medical_treatment Dermatology Young Adult 030207 dermatology & venereal diseases 03 medical and health sciences Insulin Infusion Systems 0302 clinical medicine medicine Humans Immunology and Allergy 030212 general & internal medicine Glucose sensors Surgical Tape Child Allergic contact dermatitis Retrospective Studies Type 1 diabetes Camphanes business.industry Blood Glucose Self-Monitoring Insulin Patch test Allergens Middle Aged Patch Tests medicine.disease Diabetes Mellitus Type 1 Acrylates Child Preschool Abietanes Dermatitis Allergic Contact Isobornyl acrylate Female business Contact dermatitis Resins Plant |
| Zdroj: | Contact Dermatitis. 84:75-81 |
| ISSN: | 1600-0536 0105-1873 2015-2019 |
| DOI: | 10.1111/cod.13664 |
| Popis: | Background The number of patients with contact dermatitis from glucose sensors and insulin infusion sets is increasing. Patch testing is challenging because of a lack of information concerning the constituent materials of medical devices. Objectives To report on products and causes of allergic reactions to glucose sensors or insulin infusion sets over a 5-year period and suggest a short screening series. Methods Analysis of patch test data from consecutive patients suspected of allergic contact dermatitis (ACD) to glucose sensors and/or insulin infusion sets from 2015-2019. Results Patient numbers increased from 4 to 15 per year; 30/38 (78.9%) were children. In 29 (76.3%), a diagnosis of allergic/probable ACD was established, mostly due to the tapes of the device or allergens in these tapes (n = 23) followed by allergens in the device housing (n = 10). Isobornyl acrylate, abitol, and colophonium were the most common allergens. Information from manufacturers was often difficult to obtain and, if accessible, inadequate. For this reason, the diagnosis was delayed for more than 1.5 years in 12 (31%) patients. Conclusions The increasing number of patients, mostly children, with ACD from devices used in treatment of type 1 diabetes demonstrates the importance of this problem. Allergies can easily be overlooked, due to the lack of mandatory labeling of the constituent materials of the devices. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|